Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke
et al (show 17 more authors) (2022) Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma. LIVER CANCER, 11 (4). pp. 354-367.


Kudo, Masatoshi ORCID: 0000-0002-4102-3474, Finn, Richard S ORCID: 0000-0003-2494-2126, Qin, Shukui, Han, Kwang-Hyub, Ikeda, Kenji, Cheng, Ann-Lii ORCID: 0000-0002-9152-6512, Vogel, Arndt ORCID: 0000-0003-0560-5538, Tovoli, Francesco ORCID: 0000-0002-8350-1155, Ueshima, Kazuomi ORCID: 0000-0002-7577-5789, Aikata, Hiroshi ORCID: 0000-0002-3409-2156
et al (show 10 more authors) (2023) Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study. Journal of hepatology, 78 (1). pp. 133-141.


Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke
et al (show 18 more authors) (2020) Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut, 69 (8). pp. 1492-1501.


Kudo, Masatoshi, Ueshima, Kazuomi, Yokosuka, Osamu, Ogasawara, Sadahisa, Obi, Shuntaro, Izumi, Namiki, Aikata, Hiroshi, Nagano, Hiroaki, Hatano, Etsuro, Sasaki, Yutaka
et al (show 13 more authors) (2018) Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 3 (6). pp. 424-432.

This list was generated on Sat Oct 14 10:33:45 2023 BST.